ResearcherZhujiang HospitalActive in the last 2 years

Peng Luo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8215-2045; OpenAlex author ID A5050960828, A5101474404. Sources: OpenAlex.

Their work

Papers: 5 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 16

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 3 papers

Papers 5

The Role of Cancer-Associated Endocrine Cells in Pancreatic Ductal Adenocarcinoma: Adaptive Response or Tumor Promoter? Last author DOI 10.1053/j.gastro.2024.11.029 ↗
Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcinoma. Co-author DOI 10.1186/s10020-024-01049-6 ↗
Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabine/Nab-Paclitaxel. Co-author DOI 10.34133/research.0937 ↗
Co-alteration of Myc and RTK-RAS pathways defines a liver-metastatic propensity and immune-cold subgroup of pancreatic adenocarcinoma. Co-author DOI 10.1016/j.gendis.2023.05.006 ↗
A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer. Last author DOI 10.3389/fonc.2022.1052132 ↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuyuan Zhang · 2 shared papers, 2024–2025 · strength 0.43
- Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6 ↗
- Paper Co-alteration of Myc and RTK-RAS pathways defines a liver-metastatic propensity and immune-cold subgroup of pancreatic … DOI 10.1016/j.gendis.2023.05.006 ↗
Xinwei Han · 2 shared papers, 2024–2025 · strength 0.43
- Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6 ↗
- Paper Co-alteration of Myc and RTK-RAS pathways defines a liver-metastatic propensity and immune-cold subgroup of pancreatic … DOI 10.1016/j.gendis.2023.05.006 ↗
Anqi Lin · 1 shared paper, 2025 · strength 0.42
- Paper The Role of Cancer-Associated Endocrine Cells in Pancreatic Ductal Adenocarcinoma: Adaptive Response or Tumor Promoter? DOI 10.1053/j.gastro.2024.11.029 ↗
Jinbao Zhang · 1 shared paper, 2022 · strength 0.22
- Paper A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cance… DOI 10.3389/fonc.2022.1052132 ↗
Xing Zhou · 1 shared paper, 2025 · strength 0.22
- Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6 ↗
Libo Wang · 1 shared paper, 2025 · strength 0.22
- Paper Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcin… DOI 10.1186/s10020-024-01049-6 ↗
Jian Zhang · 1 shared paper, 2024 · strength 0.21
- Paper Co-alteration of Myc and RTK-RAS pathways defines a liver-metastatic propensity and immune-cold subgroup of pancreatic … DOI 10.1016/j.gendis.2023.05.006 ↗
Xuejun Gong · 1 shared paper, 2025 · strength 0.19
- Paper Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabi… DOI 10.34133/research.0937 ↗
Jun Cheng · 1 shared paper, 2025 · strength 0.19
- Paper Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabi… DOI 10.34133/research.0937 ↗
Yize Mao · 1 shared paper, 2025 · strength 0.19
- Paper Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabi… DOI 10.34133/research.0937 ↗
Lizhi Liu · 1 shared paper, 2025 · strength 0.19
- Paper Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabi… DOI 10.34133/research.0937 ↗
Ningning Niu · 1 shared paper, 2025 · strength 0.19
- Paper Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabi… DOI 10.34133/research.0937 ↗
Xiaoping Yi · 1 shared paper, 2025 · strength 0.19
- Paper Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabi… DOI 10.34133/research.0937 ↗
Yixiong Li · 1 shared paper, 2025 · strength 0.19
- Paper Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabi… DOI 10.34133/research.0937 ↗
Dong Luo · 1 shared paper, 2025 · strength 0.19
- Paper Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabi… DOI 10.34133/research.0937 ↗
Qiuxia Yang · 1 shared paper, 2025 · strength 0.19
- Paper Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabi… DOI 10.34133/research.0937 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.